XML 45 R29.htm IDEA: XBRL DOCUMENT
v3.22.4

Other Income and Expenses, Net | 12 Months Ended
--- | ---
Dec. 31, 2022
Other Income And Expenses [Abstract] |
Other Income and Expenses, Net |
| 2 1. | OTHER INCOME AND EXPENSES, NET
Other income and expenses, net consisted of the following:
|  | Year ended December 31, 2022 |  |  | Year ended December 31, 2021 |  |  | Year ended December 31, 2020 |
Public funding |  |  | 177 |  |  |  | 162 |  |  |  | 231 |
Start-up and phase-out costs |  |  | (13 | ) |  |  | — |  |  |  | (8 | )
Exchange gain (loss), net |  |  | 15 |  |  |  | 7 |  |  |  | 8 |
Patent costs |  |  | (8 | ) |  |  | (10 | ) |  |  | (11 | )
Gain on sale of non-current assets |  |  | 2 |  |  |  | 5 |  |  |  | 14 |
COVID-19 incremental costs |  |  | (10 | ) |  |  | (19 | ) |  |  | (32 | )
Other, net |  |  | (4 | ) |  |  | (4 | ) |  |  | — |
Total |  |  | 159 |  |  |  | 141 |  |  |  | 202 |
The Company receives public funding from governmental bodies in several jurisdictions. Public funding is further described in Note 7. Start-up costs represent costs incurred in the ramp-up phase of the Company’s newly integrated manufacturing facilities. Phase-out costs are costs incurred during the closing stage of a Company’s manufacturing facility. Exchange gains and losses, net represent the portion of exchange rate changes on transactions denominated in currencies other than an entity’s functional currency and the changes in fair value of derivative instruments which are not designated as hedges, as described in Note 27. Patent costs mainly include legal and attorney fees and payment for claims, patent pre-litigation consultancy and legal fees. They are reported net of settlements, if any, which primarily include reimbursements of prior patent litigation costs. COVID-19 incremental costs are mainly composed of incremental expenses primarily related to sanitary measures undertaken to protect employees.

X
- References No definition available. + Details
Name: | us-gaap_OtherIncomeAndExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -URI https://asc.fasb.org/topic&trid=2122503 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 610 -URI https://asc.fasb.org/topic&trid=49130413 + Details
Name: | us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration